Gilead
Sciences, Inc. (NASDAQ:GILD) ended at
$37.10, 1.80% lower. The 52-week range of the stock is $31.73-$49.50. The stock
went down more than 14% year-to-date.
Gilead
Sciences, Inc. is a biopharmaceutical company that discovers, develops and
commercializes therapeutics. The Company has operations in North America,
Europe and Australia.
PharmAthene,
Inc. (AMEX:PIP) dropped 4.18% to $3.67. The 52-week range of
the stock is $1.13-$4.96.
The
stock opened at $3.96 and was trading within the range of $3.63-$4.01. At
today`s closing market price, the market capitalization of the company stands
at $148.41 million.
PharmAthene,
Inc. is a biodefense company engaged in the development and commercialization
of medical countermeasures against biological and chemical weapons.
MannKind
Corporation (NASDAQ:MNKD) added 0.15% to $6.69. The
52-week range of the stock is $4.76-$11.12.
The
stock opened at $6.65 and was trading within the range of $6.55-$6.77. At
today`s closing market price, the market capitalization of the company stands
at $834.71 million.
MannKind
Corporation is a biopharmaceutical company focused on the discovery,
development and commercialization of therapeutic products for diseases, such as
diabetes and cancer.]
For our full disclosure please visit - http://www.wallstreetgrand.com/disclosure.html
